• 보건행정학회지
• /
• 제21권3호
• /
• pp.425-456
• /
• 2011

Background: Organizations in the pharmaceutical industry are highly dependent on the institutional environment. The introduction of pharmacoeconomics to the decision-making on the price and reimbursement decisions became strong constraints to pharmaceutical companies in Korea. As little is known about the issue on organization-environment interaction in the healthcare field, this study aimed to figure out how pharmaceutical companies adapted to the environmental changes. Methods: A multicase study method was used, selecting eight cases among multi-national pharmaceutical companies in South Korea. In-depth interviews were conducted with the managers of these organizations, and secondary data were reviewed to complement the interviews. Results: Pharmaceutical companies viewed the new policies as a big threat and sought for actions against them. One of the most distinguishing organizational changes was to construct a Market Access department. Other strategies managing the environment such as co-optation, forecasting, and bargaining were also implemented. These changes were consistent with the predictions of Resource Dependency Theory and Institutional Theory. Conclusions: The interactions between pharmaceutical companies and institutional environments in healthcare were first explored. This study presents a new perspective on how organizations change and the motives for the changes. The findings of this case study will form the basis of further empirical studies.

• 산업융합연구
• /
• 제12권2호
• /
• pp.16-23
• /
• 2014

The aim of this study is to find the strategic industries that fulfills the on-site demands of the Gyeonggi province region related to the advancement and development of the local industries. As the results of the analysis, the 4 major strategic industries in the Gyeonggi province region were determined to be (1) electronic component, computer, visual, acoustic and telecommunication equipment manufacturing, (2) pulp, paper and paper product manufacturing, (3) medical substances and pharmaceutical product manufacturing, and (4) rubber and plastic product manufacturing. The industry of concordance between the 4 major strategic industry of the Gyeonggi province determined in this Study and the 13 future growth engine industry of Korea was the area of intelligent semiconductor. Accordingly, it was analyzed that there is a need to strategically cultivate the electrical and electronic telecommunication device industry, which is ranked the $1^{st}$among the strategic industries of Gyeonggi province by generating synergic effects with the policy of the government for nurturing of intelligent semiconductor industry.

• 대한약학회:학술대회논문집
• /
• 대한약학회 2003년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2-2
• /
• pp.200.3-200.3
• /
• 2003

Reactive oxygen species(ROS) are produced at a high rate continuously as a by-product of aerobic metabolism. Several lines of evidence provided that ROS appears to cause to develop aging and various diseases. High level of hyaluronic acid with decreased molecular weight has been detected in patients with inflammatory diseases including rheumatoid arthritis. Hyaluronidase is an endohexosaminidase that initiates the degradation of hyaluronic acid with high molecular weight. Prunus persica Batsch var. davidiana Maximowicz has been known as a korean folk medicine for treatment of neuritis and rheumatism. (omitted)

• 한국산학기술학회논문지
• /
• 제19권8호
• /
• pp.360-369
• /
• 2018

국내 제약 산업에는 2012년부터 혁신형 제약기업 인증 지원 정책이 시행되고 있다. 이 연구는 이 정책의 형성과정 및 정책만족도에 대한 이해관계자와 관련 전문가의 인식을 파악하고, 정책만족도를 설명하는 요인을 파악하기 위해 수행하였다. 혁신형 제약기업을 포함하여 제약기업, 대학, 정부출연연구소 관계자를 대상으로 이메일, 팩스 등을 통해 설문조사하였으며, 유효 응답률은 38.4% (61/159) 였다. 연구결과 정책형성과정 중 정책필요성(정책문제설정 단계)에 대한 인식이 가장 긍정적이었으며, 다른 모든 단계와 정책만족도에 대한 인식은 보통 수준이었다. 응답자 개인 변인 및 정책형성과정에 대한 인식 변인 중 정책만족도와 관련이 있는 변인을 대상으로 다중회귀분석을 통해 영향 요인을 살펴본 결과, 정책결과 및 정책집행 단계의 일부 변인이 주요 요인으로 분석되었다. 구체적으로 정책만족도에 가장 큰 영향을 미치는 요인은 인증기업의 성과(정책결과 단계)에 대한 인식인 것을 확인하였다. 또한 적정성 및 사후관리 능력(정책집행 단계)에 대한 인식 역시 정책만족도에 미치는 영향력의 크기가 유사했다. 이는 수요자의 정책만족도에는 정책결과뿐만 아니라 정책집행과정에 대한 인식이 중요하다는 것을 시사한다. 다만 정책 시행 초기에 수행되는 등의 한계로 인해 향후 추가 연구를 통해 검증 및 보완이 필요하다.

• 대한약학회:학술대회논문집
• /
• 대한약학회 2003년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2-2
• /
• pp.87.1-87.1
• /
• 2003

With the issuance of the ICH “Guidance for industry S7A Safety Pharmacology Studies For Human Pharmaceuticals” in July 2001 came the preference for the use of unanesthetized animals when evaluation the safety profile of new pharmaceutical agents. Telemetry provides a means of obtaining measurements of physiological functions in conscious animals without the problems associated with classical cardiovascular measuring methods. The Korea Institute of Toxicology (KIT) established the telemetric measurement of cardiovascular parameters, such as Blood pressure, Heart rate, ECG (PR, RR, QRS, QT and QTcB interval) under GLP conditions. (omitted)

• 방사선산업학회지
• /
• 제6권3호
• /
• pp.205-209
• /
• 2012

The decomposition of 50 pesticides present in an aqueous solution using ${\gamma}-irradiation$ from a $^{60}Co$ gamma-ray source was investigated using laboratory-scale experiment. The rates of decomposition were determined using a gas chromatography-electron capture detector (GC-ECD), high-performance liquid chromatography-photo diode array detector (HPLC-PDA), and HPLC-fluorescence detector (FLD). When the initial concentration of pesticides was 10 ppm, and the radiation dose was 2, 5, 10, 20, and 30 kGy, respectively, 14 pesticide samples showed high removal rates (>50%) at absorbed doses of more than 10 kGy. With the exception of procymidone, they were all completely removed at a 30 kGy irradiation dose. These results provide fundamental data on the reactivity between gamma-irradiation and pesticides in an aqueous solution. Further, an evaluation of the toxicity of radiolytic intermediate products is required.

• 대한약학회:학술대회논문집
• /
• 대한약학회 2003년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2-1
• /
• pp.26-26
• /
• 2003

KGMP is the one of the most important part in Drug administration system which drug industry must comply to. KGMP was revised newly with the harmonization of other countries and keep face with new technologies. The big revision point is bulk drug GMP, blood products GMP, validation guideline and standardization of injection manufacturing. (omitted)

• 약학회지
• /
• 제55권1호
• /
• pp.11-15
• /
• 2011

Zabofloxacin is a novel broad spectrum fluoroquinolone with excellent anti-pneumococcal activity. We investigated the in vitro activity of zabofloxacin against clinical isolates of gram-positive bacteria and the in vivo activity against systemic infection in mice. Zabofloxacin was very active against gram-positive bacteria except QRSA (Quinolone-resistant S. aureus) and VRE(Vancomycin-resistant Enterococci). Especially, zabofloxacin was extremely potent against clinical isolates of Streptococci. Zabofloxacin was as active as gemifloxacin against systemic infection in mice. In view of its improved antibacterial activities against gram-positive bacteria and good pharmacokinetic profiles in animals, the clinical usefulness of zabofloxacin should be established by further studies.

• Journal of Pharmaceutical Investigation
• /
• 제33권1호
• /
• pp.67-71
• /
• 2003

Drug excipients are material used in the formulation of pharmacologically active drugs. They have a variety of roles including dilutents/fillers/bulking agents, binders/adhesives, propellant, disintegrants, lubricants/dlidants, colors, flavors, coating agents, polising agents, fragrance, sweeteening agent, polymers and waxes. Excipient should be inert or inactive and does not interfere with the test. Nowadays within industry there has been a recent surge of interest in novel excipient for novel dosage forms. The purpose of the review is to introduce the administration systems of drug excipient about kinds, matters to be attended to change of excipients.

• 대한한의학방제학회지
• /
• 제12권1호
• /
• pp.93-104
• /
• 2004

Recently, more and more natural herbal products are investigated and used popularly. Pharmaceutical companies of Korea are very interested in developing herbal new drugs. And oriental doctors also need popular, modernized form of oriental drugs. The objective of this article is, first, to examine current situations of drug development in Korea, second, to know general concepts of patent and third, to think about new drug development and patent in oriental medicine's point of view. With consideration of oriental medicine's characteristics, concepts of new drug and patent should be improved. Therefore, the oriental pharmaceutical industry and developments of oriental new drugs could be inspired to further efforts.